References
- Russell-Eggitt I, Fielder AR, Levene MI, Young ID. Microphthalmos in a family. Ophthalmic Paediatr Genet 1985;6:361–368.
- Beby F, Lamonerie T. The homeobox gene Otx2 in development and disease. Exp Eye Res 2013;111:9–16.
- Ragge NK, Brown AG, Poloschek CM, et al. Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet 2005;76:1008–1022.
- Schilter KF, Schneider A, Bardakjian T, et al. OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype. Clin Genet 2011;79:158–168.
- Vincent A, Forster N, Maynes JT, et al. for the FORGE Canada Consortium, Héon E. OTX2 mutations cause autosomal dominant pattern dystrophy of the retinal pigment epithelium. J Med Genet 2014;51:797–805.
- Nolen LD, Amor D, Haywood A, et al. Deletion at 14q22-23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomalies. Am J Med Genet A 2006;140:1711–1718.
- Wyatt A, Bakrania P, Bunyan DJ, et al. Novel heterozygous OTX2 mutations and whole gene deletions in anophthalmia, microphthalmia and coloboma. Hum Mutat 2008;29:E278–283.
- Brisset S, Slamova Z, Dusatkova P, et al. Anophthalmia, hearing loss, abnormal pituitary development and response to growth hormone therapy in three children with microdeletions of 14q22q23. Mol Cytogenet 2014;28:7–17.